Compare GE Aerospace (GE) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE Aerospace vs Halozyme Therapeutics Inc. Common Stock — how do they compare? GE Aerospace trades at $306.76 (market cap $317.10B), while Halozyme Therapeutics Inc. Common Stock trades at $112.45 (market cap $12.58B). The key difference: GE Aerospace is far larger — about 25.2× Halozyme Therapeutics Inc. Common Stock's market cap, and GE Aerospace pays a 0.62% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold GE Aerospace for 111 Days and Halozyme Therapeutics Inc. Common Stock for 0 Days on average.
| GE | HALO | |
|---|---|---|
Market Cap | $317.10B | $12.58B |
Volume | 6,320,106 | 2,179,278 |
Sector | Industrials | Health |
52-Week High | $381.22 | $115.22 |
52-Week Low | $273.25 | $61.63 |
Typical Hold Time | 111 Days | 0 Days |
Enterprise Value | $326.91B | $14.49B |
Dividend Yield | 0.62% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE Aerospace trades at $303.62, down 1.86% amid broader market weakness, with technical indicators showing bearish momentum despite strong fundamentals. The company has consistently beaten earnings expectations with Q2 2026 EPS of $2.02 exceeding estimates, while revenue growth accelerated to $45.86 billion in 2025. Recent news highlights GE's $12 billion acquisition of Consolidated Precision Products to address supply chain constraints in jet engine components.
The stock presents a compelling value opportunity with a 35% upside to the consensus price target of $409.60, supported by 24 buy ratings and no sell recommendations. However, high valuation multiples and integration risks from the CPP acquisition warrant caution. Strong free cash flow generation and shareholder returns through dividends and buybacks provide downside protection.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About GE Aerospace
General Electric Company is a globally diversified technology and financial services company. The Company's products and services include aircraft engines, power generation, water processing, and household appliances to medical imaging, business and consumer financing, and industrial products.
Read more on GE →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
